Xeris Biopharma Holdings Inc
NASDAQ:XERS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xeris Biopharma Holdings Inc
NASDAQ:XERS
|
US |
|
J
|
JSR Corp
SWB:JYR
|
JP |
|
Hudson Global Inc
NASDAQ:HSON
|
US |
|
Mitrabara Adiperdana Tbk PT
IDX:MBAP
|
ID |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
Ontex Group NV
XBRU:ONTEX
|
BE |
Shareholder Yield
Current shareholder yield for XERS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
XERS Price
Xeris Biopharma Holdings Inc
| Average Annual Return | 15.93% |
| Standard Deviation of Annual Returns | 74.85% |
| Max Drawdown | -79% |
| Market Capitalization | 1.1B USD |
| Shares Outstanding | 172 640 000 |
| Percentage of Shares Shorted | 7.5% |
XERS Return Decomposition
Main factors of price return
Stock Splits
XERS's latest stock split occurred on Oct 6, 2021
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, XERS traded at 2.37 per share. Afterward, the share price was about 2.36.
The adjusted shares began trading on Oct 6, 2021. This was the only stock split in XERS's history.
